MTVA - MetaVia Inc.
1.61
0.050 3.106%
Share volume: 129,683
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$1.56
0.05
0.03%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-07-2024 | 03-20-2025 | 05-14-2025 | 08-07-2025 | 11-06-2025 | |
| Assets | ||||||
| Total Assets | 22.146 M | 16.260 M | 12.127 M | 18.459 M | 14.765 M | |
| Current Assets | 21.935 M | 16.072 M | 11.961 M | 18.315 M | 14.646 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 21.669 M | 16.017 M | 11.190 M | 17.589 M | 14.277 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 39.000 K | 34.000 K | 30.000 K | 27.000 K | 22.000 K | |
| Other Assets | 172.000 K | 154.000 K | 136.000 K | 117.000 K | 97.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 22.146 M | 16.260 M | 12.127 M | 18.459 M | 14.765 M | |
| Total liabilities | 9.193 M | 8.329 M | 7.747 M | 8.835 M | 8.434 M | |
| Total current liabilities | 9.114 M | 8.271 M | 7.710 M | 8.820 M | 8.434 M | |
| Accounts Payable | 1.017 M | 3.879 M | 3.054 M | 2.875 M | 2.599 M | |
| Other liabilities | 79.000 K | 58.000 K | 37.000 K | 15.000 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 79.000 K | 58.000 K | 37.000 K | 15.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 12.953 M | 7.931 M | 4.380 M | 9.624 M | 6.331 M | |
| Common stock | 143.637 M | 143.788 M | 143.908 M | 153.147 M | 153.231 M | |
| Retained earnings | -130.684 M | -135.857 M | -139.528 M | -143.523 M | -146.900 M |